MASE-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MASE-T, covering 2025-07-25 to 2025-07-25. Get the full timeline:
Most recent: Clinical Trial Update: ImmPACT Expanded Multiple Antigen Specific Endogenously Derived T Cells (MASE-T) to Patients With Metastatic Melanoma [Phase 1]